top of page
Search


Reduce procedure backlog by accelerating transfer to ambulatory
Millions of elective surgery procedures were postponed due to Covid-19, creating a backlog that will take months to clear. One way of...

Laurent DECORY
Jun 3, 20201 min read


Re-prioritizing Medtech launches in post-Covid world
How should Medtech companies re-visit launch priorities in post-Covid world ? By focusing on those with compelling value proposition and...

Laurent DECORY
Jun 3, 20201 min read


Post-Covid: elective procedures long re-start, telehealth explosion, reduced investments
Hospital & Health system survey give key insights for Pharma and Medtech business re-start : - elective procedure volumes will not return...

Laurent DECORY
May 24, 20201 min read


Hospital activity 40-60% down in April, patients uncomfortable to seek care
Pharma and MedTech need to anticipate healthcare restart timing and steps, and adapt customer engagement accordingly. US Hospital...

Laurent DECORY
May 24, 20201 min read


Join us on May 27th for interactive session on post-Covid 19 commercial re-start
In a challenging post-Covid time for Pharma and MedTech, assess customers needs to reallocate effort and prepare business re-start. Join...

Laurent DECORY
May 24, 20201 min read


80% elective surgeries were postponed, return to normal might take a year
Up to 80% elective surgeries and even 40% of cancer related surgeries have been canceled or postponed worldiwde due to Covid-19. It could...

Laurent DECORY
May 24, 20201 min read


Are contact-tracing apps worth the risks ?
Many countries are hoping to minimize future Covid risks with contact-tracing apps on smartphones, used to track people who have been in...

Laurent DECORY
May 17, 20201 min read


Combining checkpoint inhibitors improves cancer reduction and survival
Checkpoint inhibitors against PD-1, PD-L1, CTLA-4 are dramatically improving cancer treatment in defined patient sub-sets. Combining...

Laurent DECORY
May 17, 20201 min read


Pharma & MedTech launches in a post-Covid world
Beyond launch events and face-to-face push, how should Pharma & MedTech launch products in a post-Covid world ? Novartis has recently...

Laurent DECORY
May 17, 20201 min read


BioNTech / Pfizer Covid-19 vaccine candidate is one the most promising.
More than 50 Covid-19 candidate vaccines are in development across the biotech and pharma industry, and multiple approaches are being...

Laurent DECORY
May 17, 20201 min read


Pharma and MedTech: creating the commercial re-start plan
Despite dramatic impact during Covid19 outbreak, Pharma and MedTech are expected to be relatively protected on the long run, particularly...

Laurent DECORY
May 17, 20201 min read


Incompatible Electronic Health Records prevent identification of best treatments against Coronavirus
In a time of pandemic and accelerated digitalization, the need to compile and analyse data from procedures, treatments and health records...

Laurent DECORY
May 17, 20201 min read


Make Tele-health sustainable for Oncology patients
Covid-19 outbreak has had profound implications on daily lives and Medical practices. The dramatic reduction of patient visits to...

Laurent DECORY
May 17, 20201 min read


Measuring Covid-19 impact on MedTech industry
All industries have been impacted by Coronavirus. However, Covid-19 outbreak impact on MedTech industry is even more profound and...

Laurent DECORY
May 17, 20201 min read


Prepare Pharma & Medtech post-Covid commercial re-start
According to latest HCP and consumer surveys performed in 10 countries, Covid crisis has reduced patients visits by 45%, Rep-HCP...

Laurent DECORY
May 17, 20201 min read


How to re-start elective procedures ?
Elective surgical procedures, ie planned in advance rather than done in emergency situation, have been dramatically reduced, if not...

Laurent DECORY
May 17, 20201 min read


Make remote patient monitoring the new normal
The impact of Covid-19 outbreak has been dramatic on most industries. While most impact has been negative, it also has accelerated...

Laurent DECORY
May 17, 20201 min read


Pharma & Medtech, prepare for the new normal: sales force re-sizing, multi-channel resource plan
Health professionals, patients, and sales reps have all become digital-fluent. What are the implications for your go-to-market and...

Laurent DECORY
Apr 17, 20201 min read


Pharma & MedTech new normal: digital, patient-centered trials, automated supply chain, productivity
To shape the new normal, Pharma and Medtech companies need to push the boundaries on digital, patient-centered trial design, supply chain...

Laurent DECORY
Apr 17, 20201 min read


First clues on how Covid-19 will impact Pharma and MedTech sales
How will Covid-19 outbreak impact Pharma and MedTech sales? J&J forecast shared during the company’s first-quarter conference call give...

Laurent DECORY
Apr 17, 20201 min read
bottom of page


